- Consumer Products
- Latest 1.79
- Currency C$
- Change 0.14
- Percent Change 8.485 %
- Volume 121,903
- Wed Jul 9, 2014 04:00 PM EDT TSX data delayed 15 minutes.
12 months ended Mar 31, 2014.
Trailing 12 month results shown above.
All data is in Canadian dollars.
|Earnings||May 8||$-0.07||Aug 7||$-0.07|
12 months ended Jul 10, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
ONCOLYTICS BIOTECH INC. is a biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of human trials including a Phase III trial in head and neck cancers using REOLYSIN, its proprietary formulation of the human reovirus.